Abel K. Oyebamiji
Ede, OS, Nigeria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Retraction notice to "Green synthesis of copper oxide nanoparticles for biomedical application and environmental remediation" [Heliyon 6 (2020) e04508].
Journal: Heliyon
Published: August 12, 2026
Activity cliffs resist prediction within and across protein kinases: a leakage-controlled machine-learning analysis of structure-potency discontinuities.
Journal: Bioorganic chemistry
Published: June 27, 2026
PlasmidRiskNet: An explainable machine-learning framework for antimicrobial resistance plasmid risk stratification.
Journal: New microbes and new infections
Published: May 29, 2026
Eco-benign synthesis of spent vegetable oil-based biodiesel using thermally modified nanocrystalline snail shell catalysts: experimental, modeling and computational studies.
Journal: RSC advances
Published: March 13, 2026
Deciphering the mechanisms underlying the dual-target inhibition of carbohydrate-digesting and neurodegenerative enzymes by Syzygium aromaticum (L.) Merr. & L.M. via molecular docking and dynamics simulations.
Journal: Scientific reports
Published: January 07, 2026
Selective modulation of orexinergic receptors by neem-derived phytochemicals: Computational analysis of structure-activity relationships.
Journal: Toxicology reports
Published: April 25, 2025
Dataset on insight into inhibition capacity of cyclic tetra-amino acid based compounds as efficient crystal structure of human insulin-degrading enzyme inhibitors.
Journal: Data in brief
Published: April 05, 2025
Recent Update on siRNA Therapeutics.
Journal: International journal of molecular sciences
Published: February 01, 2025
Correction : Molecular Modeling Studies of Similar Molecules to Selective Estrogen Receptor Degrader Elacestrant as Inhibitors of SARS-COV-2.
Journal: Cell biochemistry and biophysics
Published: January 08, 2025
Evaluation of Polar Substituted Schiff Bases and 1,2,3-Triazole Hybrids as Anticancer Agents.
Journal: Chemistry & biodiversity
Published: December 15, 2024
Computer aided study on cyclic tetrapeptide based ligands as potential inhibitors of Proplasmepsin IV.
Journal: Scientific reports
Published: November 30, 2024
Unveiling the potential biochemical effects of selected heterocyclic compounds as human Type-A γ-aminobutyric acid (GABA A) Modulator: An Insilico Approach.
Journal: Biotechnology reports (Amsterdam, Netherlands)
Published: September 21, 2024
Last Updated: 09/26/2026